Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 329

Results For "patients"

3624 News Found

Roche’s Susvimo, for `wet’ age-related macular degeneration (nAMD) approved
Drug Approval | October 25, 2021

Roche’s Susvimo, for `wet’ age-related macular degeneration (nAMD) approved

The implant is surgically inserted into the eye during a one-time, outpatient procedure and refilled every six months


QurHealth launch patient care concierge programme in India
Startup | October 25, 2021

QurHealth launch patient care concierge programme in India

With the launch of QurOne, the brand aims to redefine healthcare in the country with seamless, hassle-free patient care and hyper-coordinated workflows


Novartis cancer drug trial does not meet primary end points
Biotech | October 25, 2021

Novartis cancer drug trial does not meet primary end points

The company is continuing with the evaluation of canakinumab in lung cancer, and is applying findings to the overall lung cancer development plan


WuXi ATU opens manufacturing facility in Shanghai to enhance its CTDMO services
Biotech | October 22, 2021

WuXi ATU opens manufacturing facility in Shanghai to enhance its CTDMO services

It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China


Rakuten Medical partners with Karkinos Healthcare to expand novel cancer care in India
Biotech | October 22, 2021

Rakuten Medical partners with Karkinos Healthcare to expand novel cancer care in India

This strategic collaboration will enable continued innovation in cancer care


Fujifilm AI detects Covid-19 Pneumonia
Digitisation | October 22, 2021

Fujifilm AI detects Covid-19 Pneumonia

Fujifilm India recently introduced a “Covid-19 Pneumonia Image Analysis Program” that helps in diagnosing chest CT images that helps in findings of Covid-19 pneumonia


U.S. FDA expands approval of Dupixent to include children aged 6 to 11 years
Drug Approval | October 22, 2021

U.S. FDA expands approval of Dupixent to include children aged 6 to 11 years

Dupixent is the only biologic medicine to improve lung function in children aged 6 to 11 years in a randomized Phase 3 trial, supporting potential as a best-in-class option


Zydus announces update on a randomised trial of Saroglitazar Mg in NASH
Biotech | October 22, 2021

Zydus announces update on a randomised trial of Saroglitazar Mg in NASH

Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders


ISA celebrates October as stroke awareness month
Healthcare | October 21, 2021

ISA celebrates October as stroke awareness month

India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50


India approves LumiraDX’s Antigen test kit
Medical Device | October 21, 2021

India approves LumiraDX’s Antigen test kit

The test combines sensitivity with speed and is designed to be used in health care settings to aid with rapid diagnosis of Covid-19